At the conclusion, the participant should be able to:
1) RECOGNIZE high risk lipid disorders; 2) DESCRIBE how to best treat complicated lipid disorders; 3) DISCUSS limitations of certain medications as indicated by new clinical trial data.
Questions and answers will allow for audience participation.